This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrowReprints and Permissions
Right arrow Copyright Information
Right arrow Books from ASM Press
Right arrow MicrobeWorld
Google Scholar
Right arrow Articles by Freudenmann, R. W.
Right arrow Articles by Lepping, P.
PubMed
Right arrow PubMed Citation
Right arrow Articles by Freudenmann, R. W.
Right arrow Articles by Lepping, P.

 Previous Article

Clinical Microbiology Reviews, October 2009, p. 690-732, Vol. 22, No. 4
0893-8512/09/$08.00+0     doi:10.1128/CMR.00018-09
Copyright © 2009, American Society for Microbiology. All Rights Reserved.

Delusional Infestation

Roland W. Freudenmann1* and Peter Lepping2,{dagger} Author Bios

Department of Psychiatry and Psychotherapy, University of Ulm, Ulm, Germany,1 North Wales NHS Trust, Wrexham Academic Unit, Wrexham, Wales, United Kingdom2

Summary: This papers aims at familiarizing psychiatric and nonpsychiatric readers with delusional infestation (DI), also known as delusional parasitosis. It is characterized by the fixed belief of being infested with pathogens against all medical evidence. DI is no single disorder but can occur as a delusional disorder of the somatic type (primary DI) or secondary to numerous other conditions. A set of minimal diagnostic criteria and a classification are provided. Patients with DI pose a truly interdisciplinary problem to the medical system. They avoid psychiatrists and consult dermatologists, microbiologists, or general practitioners but often lose faith in professional medicine. Epidemiology and history suggest that the imaginary pathogens change constantly, while the delusional theme "infestation" is stable and ubiquitous. Patients with self-diagnosed "Morgellons disease" can be seen as a variation of this delusional theme. For clinicians, clinical pathways for efficient diagnostics and etiology-specific treatment are provided. Specialized outpatient clinics in dermatology with a liaison psychiatrist are theoretically best placed to provide care. The most intricate problem is to engage patients in psychiatric therapy. In primary DI, antipsychotics are the treatment of choice, according to limited but sufficient evidence. Pimozide is no longer the treatment of choice for reasons of drug safety. Future research should focus on pathophysiology and the neural basis of DI, as well as on conclusive clinical trials, which are widely lacking. Innovative approaches will be needed, since otherwise patients are unlikely to adhere to any study protocol.

* Corresponding author. Mailing address: Department of Psychiatry and Psychotherapy III, University of Ulm, Leimgrubenweg 12, 89075 Ulm, Germany. Phone: 49 731 500 61411. Fax: 49 731 500 61412. E-mail: roland.freudenmann{at}uni-ulm.de

{dagger} Present address: Betsi Cadwaladr University Health Board, Wrexham Academic Unit, Wrexham, Wales, United Kingdom.

Clinical Microbiology Reviews, October 2009, p. 690-732, Vol. 22, No. 4
0893-8512/09/$08.00+0     doi:10.1128/CMR.00018-09
Copyright © 2009, American Society for Microbiology. All Rights Reserved.





Copyright © 2009 by the American Society for Microbiology.   For an alternate route to Journals.ASM.org, visit: http://intl-journals.asm.org | More Info»